Surgical Robotics After the Monopoly: What Changes When the Patents Expire
DDDr. Dereck Mush, MD, MBA
Aug 7
Carvolix
Public medtech company developing TAVIPILOT robotic guidance for transcatheter aortic valve procedures.
What they do
Carvolix, formerly Affluent Medical and listed on Euronext as CVX, submitted a 510(k) notification for the TAVIPILOT Robot in September 2026. The filing covers the robotic component used to support transcatheter aortic valve procedures.
The record
- Vertical
- Devices & Robotics
- Sub-segment
- Structural heart robotics
- Product type
- Device
- Stage
- Public
- Headquarters
- Aix-en-Provence, France
- Region
- Europe
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Devices & Robotics
Related on The Signal
The HealthTech Signal
The 8 Most Innovative MedTech Devices Right Now
From a pacemaker the size of a vitamin to a scanner that books its own follow-up, these are the devices actually changing care in 2026.
DDDr. Dereck Mush, MD, MBA
Jul 1
Biosimilars are finally gaining real market share, and the reasons are more structural than political
DDDr. Dereck Mush, MD, MBA
May 20
The AI ECG Cardiology Market After Queen of Hearts: Who the De Novo Clearance Actually Benefits
DDDr. Dereck Mush, MD, MBA
Sep 17